Short-term outcomes of aflibercept therapy for exudative age-related macular degeneration with persistent fluid on ranibizumab.

被引：0
|
作者：
Deligiannidis, Alexandros [1 ]
Kotagiri, Ajay K. [1 ,2 ]
Varma, Deepali [2 ]
Browning, Andrew [1 ]
Gupta, Rajen [1 ]
Talks, James S. [1 ]
机构：
[1] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England
[2] Sunderland Eye Infirm, Sunderland, Tyne & Wear, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 453 choroid: neovascularization;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4980
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Short-term Effectiveness of Intravitreal Aflibercept for Persistent Exudative Age-Related Macular Degeneration
    Chang, Andrew
    Broadhead, Geoffrey
    Chew, Jamie
    Zhu, Meidong
    Li, Haitao
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [2] Change of therapy from ranibizumab to aflibercept for recurrent or persistent exudative age-related macular degeneration
    Ziegler, M.
    Heimes, B.
    Book, B.
    Dietzel, M.
    Zeimer, M.
    Spital, G.
    Gutfleisch, M.
    Pauleikhoff, D.
    Lommatzsch, A.
    OPHTHALMOLOGE, 2015, 112 (05): : 435 - +
  • [3] Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
    Bakall, Benjamin
    Folk, James C.
    Boldt, H. Culver
    Sohn, Elliott H.
    Stone, Edwin M.
    Russell, Stephen R.
    Mahajan, Vinit B.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 156 (01) : 15 - 22
  • [4] Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
    Hamid, Mohamed A.
    Abdelfattah, Nizar S.
    Salamzadeh, Jamshid
    Abdelaziz, Sahar T. A.
    Sabry, Ahmed M.
    Mourad, Khaled M.
    Shehab, Azza A.
    Kuppermann, Baruch D.
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [5] Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
    Mohamed A. Hamid
    Nizar S. Abdelfattah
    Jamshid Salamzadeh
    Sahar T. A. Abdelaziz
    Ahmed M. Sabry
    Khaled M. Mourad
    Azza A. Shehab
    Baruch D. Kuppermann
    International Journal of Retina and Vitreous, 7
  • [6] Short-term Outcomes of Faricimab for Neovascular Age-related Macular Degeneration with Limited Response to Ranibizumab or Aflibercept
    Kim, Jeongmin
    Kim, Jae Hui
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (08): : 515 - 524
  • [7] Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab
    Hsu, Jason
    Obeid, Anthony
    Mellen, Phoebe L.
    Wibbelsman, Turner D.
    Konkoly, Michelle A.
    Velez, Michael R.
    Calem, Daniel B.
    Sioufi, Kareem
    Su, Daniel
    Storey, Philip
    Klufas, Michael A.
    Spirn, Marc J.
    Regillo, Carl
    Ho, Allen C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [8] Short-term results of the switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration
    Raphaelle, Despreaux
    Cohen, Salomon Y.
    Semoun, Oudy
    Zambrowski, Olivia
    Yung, Camille
    Oubraham, Hassiba
    Souied, Eric H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [9] Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
    Koike, Naoko
    Otsuji, Tsuyoshi
    Tsumura, Akiko
    Miki, Katsuaki
    Sakai, Yukio
    Nishimura, Tetsuya
    Takahashi, Kanji
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1247 - 1251
  • [10] Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
    Barthelmes, Daniel
    Campain, Anna
    Phuc Nguyen
    Arnold, Jennifer J.
    McAllister, Ian L.
    Simpson, Judy M.
    Hunyor, Alex P.
    Guymer, Robyn
    Essex, Rohan W.
    Morlet, Nigel
    Gillies, Mark C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (12) : 1640 - 1645
12345